In the Clinic: ART and Metabolic Effects

Volume 4, Issue 4.

The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans.

In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic complications to help improve outcomes and quality of life in patients living with HIV.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

New ART Agents: A Clinical Perspective

Volume 4, Issue 2.

Recently approved treatment options and new antiviral therapies still under investigation — through case-based discussion, Dr. Ethel Weld from the Division of Clinical Pharmacology and Infectious Diseases at the Johns Hopkins University School of Medicine explains how the promise of these new agents can impact current clinical practice.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

In The Clinic: Improving Outcomes in At-Risk Populations

Volume 3, Issue 8.

In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

New Advances in ART

Volume 3, Issue 6.

In this podcast about ART, Dr. Rachel Simmons from Boston University School of Medicine discusses recent research that may improve clinicians’ ability to more effectively and more safely manage their patients with HIV infection.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

HIV: Management of Concomitant Conditions

Volume 3, Issue 2.

In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common comorbid diseases, and potential drug-drug interactions between antiretroviral agents and common over-the-counter medications.

Take our post-test to claim CME credits.

To read a companion newsletter click here.